Bottom Fish Stocks (between .10 and$10)

[zenvesting]

BIPH had great PR this morning. From any other penny stock I might dismiss this as "hype", but BIPH is working with Boston Scientific on their technology.....and Boston Scientific said they're researching and developing many "game changing" technologies in an investor conference earlier this year. This PR sounds like a game changing tech. to me:

Biophan Receives Patent Rights Enabling MRI-Guided Surgery
Monday August 9, 9:29 am ET
Patent Rights Further Expand Biophan's Burgeoning IP Portfolio Supporting Company's Leadership Position in MRI-Safe Technologies


ROCHESTER, N.Y.--(BUSINESS WIRE)--Aug. 9, 2004-- Biophan Technologies, Inc. (OTC BB: BIPH - News), a leading developer of next-generation biomedical technology, announced today that a broad U.S. Patent has been issued to Nanoset, LLC, Biophan's technology partner with Biophan holding the worldwide exclusive rights for all medical applications. The announcement was made by Michael Weiner, Biophan's president and CEO.
ADVERTISEMENT


The Company noted that the nanomagnetic particle coating technology can illuminate devices that are currently difficult to see, either because they are invisible to MRI or because the devices occlude the MRI image. Combined with Biophan's safety solutions, the patented technology is expected to help pave the way to allowing MRI-guided surgical procedures, including minimally invasive procedures such as those used for placing stents, performing RF ablation, angiograms, biopsy probes, and many other procedures.

"Biophan's mission of creating a world-class biomedical patent portfolio is further supported by the addition of these patent rights to our burgeoning portfolio," stated Mr. Weiner. "It provides further evidence of our clear leadership position in developing technologies that make medical devices, such as pacemakers and guidewires, safe for use with MRI. The potential impact of MRI-guided surgery is far reaching and we are pleased to be on the forefront of this revolution."

Mr. Weiner continued, "It is clear that we are meeting our publicly stated objective for further innovation and market expansion. We are pleased to add these patents to our proprietary technology base."

Mr. Weiner went on to note, "Today, most interventional procedures are done under CT scan or fluoroscopy, exposing the patient and physician to ionizing radiation, and providing a less than optimal image of tissue, organs, and vessels. This is done in part because of the problems that have been associated with MRI safety and image problems associated with many medical devices. The significance of this patent is that it teaches how a coating on the device can change the MRI image, reducing the artifacts, and making the invisible devices, such as certain catheters, visible."

Mr. Weiner concluded, "Possibly what is of greatest commercial significance is our expanded dialog with the MRI manufacturers and medical device manufacturers as both groups benefit from seeing this transition to the MRI-guided surgical center. We have found considerable interest and support in seeing these capabilities reach the market. We have previously indicated that we are in discussions with biomedical device companies, with some of these discussions in advanced stages of negotiation. This patent is an important component of the evolving industry interest."

U.S. Patent No. 6,765,144 was issued to Nanoset, LLC, a technology supplier to Biophan, with Biophan holding the worldwide exclusive rights to all medical applications. Biophan and Nanoset worked jointly on the innovation, based on earlier nanotechnology patents developed by Nanoset. A copy of the patent can be viewed on the Company's website at http://www.biophan.com/intellectual.php.

A graphical illustration of the potential use of this technology can be viewed at http://www.biophan.com/mriguided1.php.

About Nanoset, LLC

Nanoset, LLC, based in East Rochester, NY, develops nanomagnetic particle coatings. Nanoset's research and development has been conducted with Alfred University, a world leader in ceramics and thin-film coatings. Nanoset and Biophan are jointly developing technologies for the medical device industry.

About Biophan Technologies

Biophan Technologies develops and markets cutting-edge technologies designed to make biomedical devices safe and compatible with magnetic resonance imaging (MRI) equipment. The Company develops enabling technologies for implanted medical systems such as pacemakers, and interventional surgical devices such as catheters and guidewires, as well as stents and other implants that can be safely and effectively imaged under MRI. The technology is also being used to create enhanced MRI contrast agents. Committed to growth through innovation and developmental leadership, Biophan and its licensors have 16 issued U.S. patents and 60 patents pending, in areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, biothermal batteries, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com.